12194 J. Am. Chem. Soc., Vol. 120, No. 47, 1998
Yamada et al.
Ala-Glu(OC12H25)2, 1.87 g, 93%): TLC Rf 0.43; IR (neat) ν(N-H)
3260 cm-1, νas(CH2) 2920 cm-1, νs(CH2) 2840 cm-1, ν(CdO, ester)
54H, 27CH2 in long chain), 1.72(brs, 2H, N+CH2CH2), 1.95 (brs, 2H,
OCOCH2CH2 in Glu), 2.05-2.50 (brm, 4H, NCOCH2 and OCOCH2),
3.20-3.65 (brs, 11H, CH2N+(CH3)3), 3.75-4.20 (brm, 8H, 2COOCH2
and 2CH2 in Gly), 4.20-4.75 (brm, 1H, CH in Glu). Anal. Calcd for
C47H91N4O7Br‚3/2H2O: C, 60.62; H, 10.17; N, 6.02. Found: C, 60.59;
H, 10.15; N, 5.77.
1740 cm-1, ν(CdO, amide I) 1640 cm-1, δ(N-H, amide II) 1540 cm-1
.
The IR spectra contained no Boc-Ala-Ala-Glu(OC12H25)2, and TLC
indicated that no other impurity was included; hence, the material was
used in the next synthesis without further purification.
Into a mixture of H-Ala-Ala-Glu(OC12H25)2 (1.87 g, 2.99 mmol) and
11-bromoundecanoic acid (0.95 g, 3.95 mmol) in 30 mL of dry THF
was added Et3N (0.36 g, 3.59 mmol) at once. To the mixture was
added a solution of diethyl phosphorocyanidate (0.58 g, 3.59 mmol)
in 30 mL of dry THF within 15 min with stirring at a temperature
below 5 °C. The mixture was allowed to stand overnight at room
temperature, filtered, dried over dry magnesium sulfate, and evaporated
to dryness in vacuo. The residual solids were dissolved in chloroform,
washed with saltwater, evaporated, and recrytallized twice from
methanol to give a colorless powder 8 (1.66 g, 64%): mp 85.5-87.5
3: recrytallized from acetone containing a small amount of ethanol;
a colorless powder; mp 191.0-193.5 °C; IR (1 mM of CCl4 solution)
ν(N-H) 3280 cm-1, νas(CH2) 2927 cm-1, νs(CH2) 2853 cm-1, ν(Cd
O, ester, see Figure 4) 1734 cm-1, ν(CdO, amide I, see Figure 4) 1632
cm-1, δ(N-H, amide II, see Figure 4) 1546 cm-1; 1H NMR (60 MHz,
CDCl3) δ 0.75-1.05 (br, 18H, 2CH3 in long chain and 4CH3 in Val),
1.05-1.85 (brs, 56H, 28CH2 in long chain), 2.00 (brs, 2H, OCOCH2CH2
in Glu), 1.85-2.45 (brm, 6H, NCOCH2, OCOCH2 and 2CH(CH3)2 in
Val), 3.30-3.60 (brs, 11H, CH2N+(CH3)3), 3.80-4.20 (brm, 4H,
2COOCH2), 4.20-4.70 (brm, 3H, 3CH in Glu and Val). Anal. Calcd
for C53H103N4O7Br‚2H2O: C, 62.64; H, 10.58; N, 5.40. Found: C,
62.40; H, 10.43; N, 5.30.
°C; TLC Rf 0.66; IR (10 mM of CCl4 solution) ν(N-H) 3281 cm-1
,
νas(CH2) 2928 cm-1, νs(CH2) 2853 cm-1, ν(CdO, ester, see Figure 2)
1738 cm-1, ν(CdO, amide I, see Figure 2) 1630 and 1688 cm-1, δ(N-
4: recrytallized from acetone; a colorless powder; mp 180.0-184.0
1
H, amide II, see Figure 2) 1527 cm-1; H NMR (60 MHz, CDCl3) δ
°C; IR (1 mM of CCl4 solution) ν(N-H) 3281 cm-1, νas(CH2) 2926
cm-1, νs(CH2) 2854 cm-1, ν(CdO, ester, see Figure 4) 1736 cm-1
,
0.90 (brt, 6H, 2CH3 in long chain) 1.05-1.80 (brm, 60H, 27CH2 in
long chain and 2CH3 in Ala), 1.87 (brs, CH2CH2Br), 2.00-2.60 (brm,
6H, NCOCH2 and OCOCH2CH2 in Glu), 3.41 (t, J ) 7 Hz, 2H, CH2Br),
3.90-4.30 (m, 4H, COOCH2), 4.30-4.90 (brm, 3H, CH in Ala), 6.43
(d, J ) 7 Hz, 1H, NH in Ala), 6.85-7.40 (brm, 2H, NH in Ala and in
Glu). Anal. Calcd for C46H86N3O7Br: C, 63.28; H, 9.93; N, 4.81.
Found: C, 63.33; H, 10.31; N, 4.89.
ν(CdO, amide I, see Figure 4) 1632 cm-1, δ(N-H, amide II, see Figure
4) 1546 cm-1; 1H NMR (60 MHz, CDCl3) δ 0.60-1.05 (br, 18H, 2CH3
in long chain and 2CH(CH3)CH2CH3 in Ile) 1.10-1.90 (brs, 64H,
29CH2 in long chain, 2CH(CH3)CH2CH3 in Ile and OCOCH2CH2 in
Glu), 2.00-2.60 (br, 6H, OCOCH2, NCOCH2 and 2CH(CH3)CH2CH3
in Ile), 3.20-3.60 (brs, 11H, CH2N+(CH3)3), 3.80-4.40 (brm, 4H,
2COOCH2), 4.40-4.70 (brm, 3H, 3CH in Glu and Ile). Anal. Calcd
for C55H107N4O7Br‚1H2O: C, 63.86; H, 10.62; N, 5.42. Found: C,
63.83; H, 10.56; N, 5.47.
N-[N-[N-(11-Trimethylammonioundecanoyl)-L-alanyl]-L-alanyl]-
O,O′-didodecyl-L-glutamate Bromide (2). The resultant bromide 8
(1.34 g, 1.87 mmol) was dissolved in 100 mL of dry THF. Dry Me3N
gas was bubbled into the solution under vigorous stirring with ice
cooling until the total volume of the solution slightly increased. The
flask was stoppered and allowed to stand for 1 week at room
temperature in the dark. The solvent and excess Me3N were removed
under reduced pressure. In this procedure, simultaneous use of an amine
trap and a hood was required because Me3N has an extremely bad odor.
The residual solid was twice recrystallized from acetone to give a
colorless powder (2, 1.24 g, 71%): mp 103.5-106.0 °C; TLC Rf 0
(there is no developed component); IR (1 mM of CCl4 solution) ν(N-
H) 3399 cm-1, νas(CH2) 2921 cm-1, νs(CH2) 2852 cm-1, ν(CdO, ester,
see Figure 2) 1747 and 1728 cm-1, ν(CdO, amide I, see Figure 2)
1647 and 1631 cm-1, δ(N-H, amide II, see Figure 2) 1560 and 1534
cm-1; 1H NMR (500 MHz, CDCl3) δ 0.82 (t, 6H, 2CH3 in long chain),
1.15-1.40 (brm, 54H, 24CH2 in long chain and 2CH3 in Ala), 1.48-
1.60 (m, 6H, 2COOCH2CH2 and NCOCH2CH2), 1.77 (brs, 2H, N+-
CH2CH2), 1.90-2.10 (m, OCOCH2CH2 in Glu), 2.20 (brs, 2H,
NCOCH2), 2.25-2.40 (m, 2H, OCOCH2 in Glu), 3.37 (s, 9H,
N+(CH3)3), 3.60 (brs, 2H, N+CH2), 3.92-4.05 (m, 4H, 2COOCH2),
4.31-4.37 (m, 1H, CH in Glu), 4.42 (brs, 2H, CH in Ala), 7.44 (brs,
1H, NH in Ala), 7.59 (brs, 1H, NH in Ala), 7.83 (brs, 1H, NH in Glu).
Anal. Calcd for C49H95N4O7Br‚1H2O: C, 61.94; H, 10.29; N, 5.90.
Found: C, 61.92; H, 10.08; N, 5.87.
5: recrytallized from acetone; a colorless powder; mp 109.0-111.5
°C; IR (1 mM of CCl4 solution) ν(N-H) 3282 cm-1, νas(CH2) 2925
cm-1, νs(CH2) 2854 cm-1, ν(CdO, ester) 1737 cm-1, ν(CdO, amide
I) 1637 cm-1, δ(N-H, amide II) 1542 cm-1 1H NMR (500 MHz,
;
CDCl3) δ 0.88 (t, J ) 7 Hz, 6H, 2CH3 in long chain), 1.10-1.40 (brm,
48H, 24CH2 in long chain), 1.51-1.53 (m, 6H, 2COOCH2CH2 and
NCOCH2CH2), 1.77 (brs, 2H, N+CH2CH2), 2.00-2.25 (m, 2H,
OCOCH2CH2 in Glu), 2.35-2.50 (m, 4H, NCOCH2 and OCOCH2 in
Glu), 3.00-3.20 (m, 4H, CH2Ar in Phe), 3.28 (s, 9H, N+(CH3)3), 3.50-
3.58 (brm, 2H, N+CH2), 4.00-4.10 (m, 4H, 2COOCH2), 4.45-4.51
(m, 1H, CH in Glu), 4.64-4.80 (m, 2H, 2CH in Phe), 7.15-7.25 (m,
10H, Ar-H in Phe), 7.50 (brs, 1H, NH in Glu or Phe), 8.35 (brs, 1H,
NH in Glu or Phe), 8.65 (brs, 1H, NH in Glu or Phe). This spectrogram
was shown in ref 5. Anal. Calcd for C61H103N4O7Br‚2H2O: C, 65.39;
H, 9.63; N, 5.00. Found: C, 65.31; H, 9.66; N, 4.99.
6: recrytallized from acetone; a colorless powder; mp 100.0-101.8
°C; IR (1 mM of CCl4 solution) ν(N-H) 3280 cm-1, νas(CH2) 2926
cm-1, νs(CH2) 2854 cm-1, ν(CdO, ester) 1737 cm-1, ν(CdO, amide
I) 1632 cm-1, δ(N-H, amide II) 1543 cm-1; 1H NMR (60 MHz, CDCl3)
δ 0.88 (t, J ) 7 Hz, 6H, 2CH3 in long chain), 1.10-1.50 (brm, 54H,
27CH2 in long chain), 1.77 (brm, 2H, N+CH2CH2), 2.00-2.80 (brm,
10H, OCOCH2CH2 in Glu, SCH2CH2 in Met and NCOCH2), 2.10 (s,
6H, 2SCH3), 3.40 (s, 9H, N+(CH3)3), 3.50 (s, 2H, N+CH2), 3.90-4.27
(brm, 4H, 2COOCH2), 4.38-4.90 (brm, 3H, 3CH in Glu and Met),
7.17 (brs, 1H, NH in Glu or Met), 7.57 (brs, 1H, NH in Glu or Met),
7.75 (d, J ) 6 Hz, 1H, NH in Glu or Met). Anal. Calcd for
C53H103N4O7S2Br‚H2O: C, 59.47; H, 9.89; N, 5.23. Found: C, 59.22;
H, 10.06; N, 5.10.
Other Amphiphiles. Other double-chain, tripeptide-containing
amphiphiles 1, 3-7 were prepared in the same manner as that described
above. The single-chain, tripeptide-containing amphiphiles 9-11 were
synthesized using the corresponding dodecyl amino acid instead of
didodecyl-L-glutamate, which procedure has been reported elsewhere.7
The amphiphile 12 whose tripeptide part had an opposite direction was
synthesized as follows. 10-Bromodecyloxy-L-phenylalaninate hydro-
chloride was condensed with Boc-Phe-Phe-OH in the same manner as
that described above. After the protection group was removed, the
resulting oil was allowed to react with tridecanoic acid, which was
followed by quaternization with Me3N as described above. The
analytical data for these final compounds are shown below.
7: recrytallized from acetone; a colorless powder; mp 145.0-152.0
°C; IR (1 mM of CCl4 solution) ν(N-H) 3264 cm-1, νas(CH2) 2927
cm-1, νs(CH2) 2855 cm-1, ν(CdO, ester, see Figure 2) 1738 cm-1
,
ν(CdO, amide I, see Figure 2) 1634 cm-1, δ(N-H, amide II, see Figure
1
2) 1543 cm-1; H NMR (60 MHz, CDCl3) δ 0.70-1.10 (brm, 18H,
2CH3 in long chain, 2CH3 in Val and 2CH3 in Leu), 1.15-1.60 (brm,
54H, 27CH2 in long chain), 1.60-2.10 (br, 6H, N+CH2CH2, CH2CH-
(CH3)2 in Leu, OCOCH2CH2 in Glu), 2.10-2.70 (brm, 4H, NCOCH2
and OCOCH2 in Glu), 2.75-3.15 (brm, 2H, CH(CH3)3 in Val and
CH2CH(CH3)2 in Leu), 3.38 (s, 9H, N+(CH3)3), 3.40 (s, 9H, N+(CH3)3),
3.50 (s, 2H, N+CH2), 3.90-4.30 (brm, 4H, 2COOCH2), 4.30-4.70 (m,
3H, 3CH in Glu, Val, and Leu), 6.65 (brs, 1H, NH in Glu, Val, or
1: recrystallized from acetone; a colorless powder; mp 88.0-91.0
°C; IR (1 mM of CCl4 solution) ν(N-H) 3366 and 3319 cm-1, νas(CH2)
2924 cm-1, νs(CH2) 2852 cm-1, ν(CdO, ester, see Figure 2) 1727 and
1709 cm-1, ν(CdO, amide I, see Figure 2) 1677, 1663 and 1649 cm-1
,
1
δ(N-H, amide II, see Figure 2) 1537 and 1513 cm-1; H NMR (60
MHz, CDCl3) δ 0.80 (brt, 6H, 2CH3 in long chain), 1.00-1.65 (brm,